0.885
前日終値:
$0.8676
開ける:
$0.87
24時間の取引高:
30,682
Relative Volume:
0.01
時価総額:
$8.73M
収益:
$1.52M
当期純損益:
$-13.97M
株価収益率:
-0.2902
EPS:
-3.05
ネットキャッシュフロー:
$-13.29M
1週間 パフォーマンス:
-9.44%
1か月 パフォーマンス:
-20.27%
6か月 パフォーマンス:
+36.15%
1年 パフォーマンス:
-25.00%
Predictive Oncology Inc Stock (POAI) Company Profile
POAI を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
POAI
Predictive Oncology Inc
|
0.885 | 8.73M | 1.52M | -13.97M | -13.29M | -3.05 |
![]()
ISRG
Intuitive Surgical Inc
|
476.35 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
199.18 | 57.39B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
93.24 | 45.22B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
213.57 | 31.43B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
COO
The Cooper Companies, Inc.
|
79.47 | 15.88B | 3.90B | 392.30M | 288.10M | 1.95 |
Predictive Oncology Inc Stock (POAI) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-08-19 | 開始されました | H.C. Wainwright | Buy |
Predictive Oncology Inc (POAI) 最新ニュース
Investors Eye Biotech Sector as Cancer Therapy Market Surges (PR Newswire) - Aktiellt
Predictive Oncology (POAI) Advances in Drug Repurposing with AI Innovations | POAI Stock News - GuruFocus
Predictive Oncology Develops Novel Approach to Identifying Clinically Viable Abandoned Drugs - GlobeNewswire
Revolutionary AI Platform Revives Abandoned Cancer Drugs with Stunning Results - Stock Titan
Predictive Oncology Ends Merger Talks with Renovaro - TipRanks
Renovaro says Predictive Oncology terminates merger transaction - MSN
Health Care Stocks Tumble On Multiple Fronts - Finimize
Renovaro Biosciences faces merger setback with Predictive Oncology By Investing.com - Investing.com Canada
Renovaro Biosciences faces merger setback with Predictive Oncology - Investing.com India
Renovaro Says Predictive Oncology Terminates Merger Transaction With Co - marketscreener.com
Renovaro BioSciences (RENB) Challenges Merger Termination - GuruFocus
Renovaro Biosciences Announces Breach Of Agreement By Predictive Oncology, Legal Action Pending - Nasdaq
Renovaro Says Predictive Oncology Terminates Merger Deal; Shares Fall - MarketScreener
Renovaro Provides Update to Definitive Agreement with Predictive Oncology - GlobeNewswire
Merger Crisis: Renovaro Threatens Legal Action After Predictive Oncology Backs Out - Stock Titan
Predictive Oncology Reports 2024 Financial Results and Merger Plans - TipRanks
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update - GlobeNewswire
Predictive Oncology pushing forward with Renovaro merger despite $10.8M loss in 2024 - The Business Journals
Predictive Oncology Advances AI Merger Plans Despite $10.8M Loss: Key Strategic Moves Revealed - Stock Titan
Predictive Oncology Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Predictive Oncology (POAI) Uses AI to Slash Drug Discovery Timelines & Boost Cancer Research - Insider Monkey
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Predictive Oncology developed predictive models from 21 compounds from NPDC - TipRanks
Predictive Oncology Successfully Develops Predictive Models - GlobeNewswire
Predictive Oncology (POAI) Stock Surges Following Major Drug Discovery Breakthrough - Stocks Telegraph
Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary - The Manila Times
Predictive Oncology Develops Advanced Predictive Models for Natural Compounds in Cancer Drug Discovery - Nasdaq
Top 8 AI News Updates Driving Markets Today - Insider Monkey
Milestone Merger Payment with Predictive Oncology to Advance AI - newschannelnebraska.com
Predictive Oncology Sells Skyline Medical Assets To DeRoyal Industries - Nasdaq
Predictive Oncology Sells Skyline Medical Assets to DeRoyal Industries - citybiz
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries to Focus on AI-Driven Drug Discovery - Nasdaq
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries - GlobeNewswire
Strategic Pivot: Predictive Oncology Divests Medical Assets for AI-Powered Future - Stock Titan
Predictive Oncology (POAI) Expected to Announce Earnings on Thursday - Defense World
Predictive Oncology to launch ChemoFx assay in Europe - MSN
Predictive Oncology receives financing from Renovaro Biosciences - Pennsylvania Business Report -
Renovaro (RENB) and Predictive Oncology Partner for AI-Driven Drug Discovery: What’s Next for Cancer and HIV Treatments? - Insider Monkey
Renovaro provides financing to Predictive Oncology as both move to finalize definitive merger agreement - The Business Journals
MarketsMedicine Hat News - Financial Content
Milestone Merger Payment made with Predictive Oncology to Advance AI-Driven Biomarker Discovery and Precision Medicine in Cancer and Beyond: Renovaro, Inc. (NASDAQ: RENB) - The Globe and Mail
Milestone Merger Payment made with Predictive Oncology - openPR
Renovaro Completes First Milestone Payment To Finalize Definitive Agreement With Predictive Oncology - Marketscreener.com
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology - GlobeNewswire
Predictive Oncology Moves To Finalize Definitive Merger Agreement With Renovaro Biosciences - Marketscreener.com
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences - The Manila Times
Renovaro completes first milestone payment for Predictive Oncology deal - TipRanks
Renovaro Biosciences Advances Financing for AI-Driven Integration and Strategic Expansion in Oncology through Acquisition of Predictive Oncology - Nasdaq
Can Renovaro's AI Oncology Merger Unlock Value From 150,000+ Tumor Samples? - StockTitan
Can This AI-Powered Oncology Merger Transform Cancer Treatment? First Financing Milestone Reached - StockTitan
Predictive Oncology Inc (POAI) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):